Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: A potential method for therapeutic drug monitoring

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 4, 2007, Pages 963-969

  Allanson, A L ^a   Cotton, M M ^b   Tettey, J N A ^a   Boyter, A C ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

Dried blood spots; HPLC; Rifampicin; Therapeutic drug monitoring; Tuberculosis

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; PAPAVERINE; RIFAMPICIN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG ISOLATION; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; THAWING; ULTRAVIOLET SPECTROSCOPY;

ANTIBIOTICS, ANTITUBERCULAR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG MONITORING; HUMANS; INDICATORS AND REAGENTS; LINEAR MODELS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; RIFAMPIN; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 34547112832     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2007.04.007     Document Type: Article

References (20)

1. Storey A. Pharm. J. 273 (2004) 289-291
2. CDC Guidelines on the shipment of dried blood spot specimens http://www.cdc.gov/od/ohs/biosfty/driblood.htm (15/09/05).
3. Mandell G.L., Bennett J.E., and Dolin R. Principles and Practise of Infectious Diseases. 4th ed. (1995), Churchill Livingston, London pp. 2226-2228
4. WHO for TB/HIV: http://www.who.int/tb/hiv/faq/en/index.html (15/09/05).
5. Shishoo C.J., Shah S.A., Rathod I.S., Savale S.S., Kotecha J.S., and Shah P.B. Int. J. Pharm. 190 (1999) 109-123
6. Smith P.J., van Dyk J., and Fredericks A. Int. J. Tuberc. Lung Dis. 3 (1999) S325-S328
7. Swart K.J., and Papgis M.J. J. Chromatogr. 593 (1992) 21-24
8. Ye L., Stewart J.T., and Zhang H.L. J. Pharm. Biomed. Anal. 13 (1995) 1185-1188
9. Agrawal S., Kaur K.J., Singh I., Bhade S.R., Kaul C.L., and Panchagnula R. Int. J. Pharm. 233 (2002) 169-177
10. Calleja I., Blanco-Prieto M.J., Ruz N., Renedo M.J., and Dios-Vieitez M.C. J. Chromatogr. A 1031 (2004) 289-294
11. Mohan B., Sharda N., and Singh S.J. J. Pharm. Biomed. Anal. 31 (2003) 607-612
12. Panchagnula R., Sood A., Sharda N., Kaur K., and Kaul C.L. J. Pharm. Biomed. Anal. 18 (1999) 1013-1020
13. Bartels H., and Bartels R.J. J. Chromatogr. B 686 (1996) 235-240
14. Oliveira E.J., Watson D.G., and Morton N.S. J. Pharm. Biomed. Anal. 29 (2002) 803-809
15. Lau Y.Y., Hanson G.D., and Carel B.J. J. Chromatogr. B 676 (1996) 147-152
16. Lecaillon J.B., Febvre N., Metayer J.P., and Souppart C. J. Chromatogr. 145 (1978) 319-324
17. Workshop on GMP & QA of multisource tuberculosis medicines, KL, 2005, Stability Studies. Theo Dekker DSC. Consultant to WHO Research Institute for Industrial Pharmacy, North West University, Potschefstroom, South Africa.
18. United States Pharmacopoeia, 4th ed., 2005.
19. Vekey K., Edwards D.M., and Zirilli L.F. J. Chromatogr. 474 (1989) 317-327
20. Mandell G.L., Bennett J.E., and Dolin R. Principles and Practise of Infectious Diseases. 4th ed. (1995), Churchill Livingstone, New York p. 318